First Patient Treated with Proton Therapy at Lynn Cancer Institute - Top-Institutions - MDSpire

First Patient Treated with Proton Therapy at Lynn Cancer Institute

The Eugene M. & Christine E. Lynn Cancer Institute at Boca Raton Regional Hospital, part of Baptist Health, reached an important milestone in the advancement of cancer care with the successful treatment of its first patient utilizing proton therapy, according to physicians at both the Institute and the hospital.

  • May 15, 2026

  • 5 min

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    Eugene M. & Christine E. Lynn Cancer Institute
    Eugene M. & Christine E. Lynn Cancer Institute

    Boca Raton, Florida

    Key Differentiators

    • Oncology

  • #2

    Massachusetts General Hospital
    Massachusetts General Hospital

    Boston, Massachusetts

    Key Differentiators

    • Oncology

  • #3

    Winship Cancer Institute of Emory University
    Winship Cancer Institute of Emory University

    Atlanta, Georgia

    Key Differentiators

    • Oncology

  • #4

    The University of Texas MD Anderson Cancer Center
    The University of Texas MD Anderson Cancer Center

    Houston, Texas

    Key Differentiators

    • Oncology

  • #5

    Boca Raton Regional Hospital
    Boca Raton Regional Hospital

    Boca Raton, Florida

    Key Differentiators

    • Oncology

Original Source(s)

First Patient Treated with Proton Therapy at Lynn Cancer Institute

  • May 15, 2026

Related Content

Inside the Rise of circRNA

Circio CEO Erik Wiklund reflects on the discovery of human circular RNA and its evolution into a fast-moving therapeutic modality

  • July 9, 2026

  • 12 min
Dana-Farber Research Supports FDA Approval of New First-Line Therapy for Metastatic Triple-Negative Breast Cancer

The U.S. Food and Drug Administration (FDA) has approved the antibody-drug conjugate sacituzumab govitecan for first-line treatment of metastatic triple-negative breast cancer.

  • by

  • June 24, 2026

  • 4 min
ESMO Breast Cancer 2026 Highlights: Saci-IO HR+

Harold Burstein, MD, PhD, and Ana C. Garrido-Castro, MD discuss results from the Saci-IO HR+ trial, which were presented at the 2026 ESMO Breast Cancer Congress.

  • June 26, 2026

  • 1 min